Cited by 271MicroRNA in disease regulationAngiogenesis and VEGF in CancerNitric Oxide and Endothelin Effects

The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.

MicroRNA‐320 EXPRESSION IN MYOCARDIAL MICROVASCULAR ENDOTHELIAL CELLS AND ITS RELATIONSHIP WITH INSULIN‐LIKE GROWTH FACTOR‐1 IN TYPE 2 DIABETIC RATS

Wang, XH, Qian, RZ, Zhang, W, Chen, SF, Jin, HM, Hu, RM·2009·Clinical and Experimental Pharmacology and Physiology

DOI 10.1111/j.1440-1681.2008.05057.x

Open this paper in CoChat — free account

Abstract

SUMMARY: The aim of the present study was to determine the role of myocardial microvascular endothelial cells (MMVEC) in impaired angiogenesis of type 2 diabetic Goto‐Kakizaki (GK) rats. A microRNA (miRNA) microarray was used to assess miRNA expression in MMVEC from GK and Wistar rats. Upregulation of miRNA‐320 was observed in MMVEC from GK rats using real‐time reverse transcription–polymerase chain reaction (RT‐PCR). So far, nine miRNAs have been reported to target angiogenic factors and/or receptors, including kinase insert domain containing receptor (Flk‐1), insulin‐like growth factor 1 (IGF‐1) and insulin‐like growth factor 1 receptor (IGF‐1R). The predicted genes targeted by miR‐320 include Flk‐1, IGF‐1 and IGF‐1R. Western blot analysis and RT‐PCR were used to analyse the protein and mRNA expression, respectively, of the putative genes IGF‐1 and IGF‐1R. The expression of IGF‐1 and IGF‐1R proteins decreased significantly in diabetic MMVEC. However, the expression of IGF‐1 mRNA increased rather than decreased. The mRNA expression of IGF‐1R did not differ significantly between diabetic and control MMVEC. Transfection of an miR‐320 inhibitor into MMVEC from GK rats confirmed that miR‐320 impaired angiogenesis. The proliferation and migration of diabetic MMVEC improved after transfection of the miR‐320 inhibitor. In addition, the miR‐320 inhibitor significantly increased the expression of IGF‐1 protein, but had no effect on the expression of IGF‐1R. Eleven miRNAs were upregulated in MMVEC from GK rats compared with those in Wistar rats: let‐7e, miR‐129, miR‐291‐5p, miR‐320, miR‐327, mir‐333, miR‐363–5p, miR‐370, miR‐494, miR‐503 and miR‐664. The results indicate that upregulation of miR‐320 in MMVEC from GK rats may be responsible for the inconsistency between the expression of IGF‐1 protein and mRNA and therefore related to impaired angiogenesis in diabetes. Transfection of an miR‐320 inhibitor may be a therapeutic approach for the treatment of impaired angiogenesis in diabetes.

Integrity signals

Registry

Crossref · 10.1111/j.1440-1681.2008.05057.x

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Untitled work
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
Prediction of Mammalian MicroRNA Targets
Lewis, B. P., Shih, I.-H., Jones-Rhoades, M. W., Bartel, D. P., & Burge, C. B. (2003) · Cell · doi:10.1016/s0092-8674(03)01018-3 · Cited by 5,199
The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans
Reinhart, B. J., Slack, F. J., Basson, M., Pasquinelli, A. E., Bettinger, J. C., Rougvie, A. E., Horvitz, H. R., & Ruvkun, G. (2000) · Nature · doi:10.1038/35002607 · Cited by 4,989
Combinatorial microRNA target predictions
Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
Human MicroRNA Targets
John, B., Enright, A. J., Aravin, A., Tuschl, T., Sander, C., & Marks, D. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020363 · Cited by 3,796
MicroRNAs Modulate Hematopoietic Lineage Differentiation
Chen, C.-Z., Li, L., Lodish, H. F., & Bartel, D. P. (2004) · Science · doi:10.1126/science.1091903 · Cited by 3,257
The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation
Chen, J., Mandel, E. M., Thomson, J. M., Wu, Q., Callis, T. E., Hammond, S. M., Conlon, F. L., & Wang, D.-Z. (2005) · Nature Genetics · doi:10.1038/ng1725 · Cited by 2,807

Show all 38 references

Research works printed but not linked: 1

Ning YX, 2005, Study on the cytological characteristics of rat myocardium microvascular endothelial cells in culture of primary passage by microarray, Chin. J. Pathophysiol, 21, 2295

Sorted by citations

Items 101–200 of 269

MicroRNA Signature and Cardiovascular Dysfunction
Arunachalam, G., Upadhyay, R., Ding, H., & Triggle, C. R. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000178 · Cited by 52
Knockdown of long noncoding RNA XIST alleviates oxidative low-density lipoprotein-mediated endothelial cells injury through modulation of miR-320/NOD2 axis
Xu, X., Ma, C., Liu, C., Duan, Z., & Zhang, L. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.06.042 · Cited by 47
Subclinical Detection of Diabetic Cardiomyopathy with MicroRNAs: Challenges and Perspectives
León, L. E., Rani, S., Fernández, M., Larico, M., & Calligaris, S. D. (2015) · Journal of Diabetes Research · doi:10.1155/2016/6143129 · Cited by 44
Pathological Effects of Exosomes in Mediating Diabetic Cardiomyopathy
Salem, E., & Fan, G. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-4397-0_8 · Cited by 42
Mechanisms of Protective Effects of SGLT2 Inhibitors in Cardiovascular Disease and Renal Dysfunction
Liu, B., Wang, Y., Zhang, Y., & Yan, B. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190828161409 · Cited by 43
Association of miRNA − 320 expression level and its target gene endothelin-1 with the susceptibility and clinical features of polycystic ovary syndrome
Rashad, N. M., Ateya, M. A.-M., Saraya, Y. S., Elnagar, W. M., Helal, K. F., Lashin, M. E.-B., Abdelrhman, A. A., Alil, A. E., & Yousef, M. S. (2019) · Journal of Ovarian Research · doi:10.1186/s13048-019-0513-5 · Cited by 43
Modulation of microRNAs in hypertension-induced arterial remodeling through the β1 and β3-adrenoreceptor pathways
Ling, S., Nanhwan, M. K., Qian, J., Kodakandla, M., Castillo, A. C., Thomas, B., Liu, H., & Ye, Y. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.10.003 · Cited by 40
Epigenetics and Cardiovascular Disease in Diabetes
Pasquier, J., Hoarau-Véchot, J., Fakhro, K. A., Rafii, A., & Khalil, C. A. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0677-3 · Cited by 41
Sexual Dimorphism of miRNAs Secreted by Bovine In vitro-produced Embryos
Gross, N., Schmidt, J. K., & Khatib, H. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00039 · Cited by 40
Involvement of aberrant regulation of epigenetic mechanisms in the pathogenesis of Parkinson's disease and epigenetic‐based therapies
Renani, P. G., Taheri, F., Rostami, D., Farahani, N., Abdolkarimi, H., Abdollahi, E., Taghizadeh, E., & Hayat, S. M. G. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28622 · Cited by 43
MicroRNAs As Master Regulators of Atherosclerosis: From Pathogenesis to Novel Therapeutic Options
Hosen, M. R., Goody, P. R., Zietzer, A., Nickenig, G., & Jansen, F. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8107 · Cited by 40
Interplay between histopathological alterations, cigarette smoke and chemopreventive agents in defining microRNA profiles in mouse lung
Izzotti, A., Larghero, P., Balansky, R. M., Pfeffer, U., Steele, V. E., & Flora, S. D. (2010) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2010.10.003 · Cited by 39
Glioblastoma Exosomes for Therapeutic Angiogenesis in Peripheral Ischemia
Monteforte, A. J., Lam, B., Sherman, M. B., Henderson, K., Sligar, A. D., Spencer, A., Tang, B., Dunn, A. K., & Baker, A. B. (2017) · Tissue Engineering Part A · doi:10.1089/ten.tea.2016.0508 · Cited by 39
miR-503 Is Involved in the Protective Effect of Phase II Enzyme Inducer (CPDT) in Diabetic Cardiomyopathy via Nrf2/ARE Signaling Pathway
Miao, Y., Wan, Q., Liu, X., Wang, Y., Luo, Y., Liu, D., Lin, N., Zhou, H., & Zhong, J. (2017) · BioMed Research International · doi:10.1155/2017/9167450 · Cited by 38
MiR-664a-3p expression in patients with obstructive sleep apnea
Li, K., Chen, Z., Qin, Y., & Wei, Y. (2018) · Medicine · doi:10.1097/md.0000000000009813 · Cited by 38
Posttranscriptional Regulation of Insulin Resistance: Implications for Metabolic Diseases
Pérez-García, A., Torrecilla-Parra, M., Frutos, M. F.-D., Martín-Martín, Y., Pardo, V., & Ramírez, C. M. (2022) · Biomolecules · doi:10.3390/biom12020208 · Cited by 45
Down-Regulation of miR-327 Alleviates Ischemia/Reperfusion-Induced Myocardial Damage by Targeting RP105
Yang, Y., Yang, J., Liu, X., Ding, J., Li, S., Guo, X., Yang, C., Fan, Z., Wang, H., Li, Q., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000493288 · Cited by 37
MicroRNA-23a is involved in tumor necrosis factor-α induced apoptosis in mesenchymal stem cells and myocardial infarction
Mao, J., Lv, Z., & Zhuang, Y. (2014) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2013.11.005 · Cited by 42
Distinctive Profile of IsomiR Expression and Novel MicroRNAs in Rat Heart Left Ventricle
McGahon, M. K., Yarham, J. M., DALY, A. B., Guduric‐Fuchs, J., Ferguson, L. J., Simpson, D. A. C., & Collins, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065809 · Cited by 36
Potential Roles of Muscle-Derived Extracellular Vesicles in Remodeling Cellular Microenvironment: Proposed Implications of the Exercise-Induced Myokine, Irisin
Darkwah, S. O., Park, E. J., Myint, P. K., Ito, A., Appiah, M. G., Obeng, G., Kawamoto, E., & Shimaoka, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.634853 · Cited by 38
MicroRNAs as newer therapeutic targets: A big hope from a tiny player
Ghelani, H., Rachchh, M., & Gokani, R. H. (2012) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.99416 · Cited by 36
Pathogenesis of diabetic cerebral vascular disease complication
Xu, R. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i1.54 · Cited by 37
Epigenetic silencing of MicroRNA-503 regulates FANCA expression in non-small cell lung cancer cell
Li, N., Zhang, F., Li, S., & Zhou, S. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.01.103 · Cited by 35
MicroRNAs, DNA damage response and ageing
Majidinia, M., Mir, S. M., Mirza‐Aghazadeh‐Attari, M., Asghari, R., Kafil, H. S., Safa, A., Mahmoodpoor, A., & Yousefi, B. (2020) · Biogerontology · doi:10.1007/s10522-020-09862-2 · Cited by 38
Micromanaging aging with miRNAs: new messages from the nuclear envelope
Ugalde, A. P., Español, Y., & López-Otín, C. (2011) · Nucleus · doi:10.4161/nucl.2.6.17986 · Cited by 34
Cellular MicroRNAs 498 and 320d Regulate Herpes Simplex Virus 1 Induction of Kaposi’s Sarcoma-Associated Herpesvirus Lytic Replication by Targeting RTA
Yan, Q., Wan, L., Tang, Q., Yao, S., Lv, Z., Feng, N., Ma, X., Bai, Z., Zeng, Y., Qin, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055832 · Cited by 34
Synergy of microRNA and Stem Cell: A Novel Therapeutic Approach for Diabetes Mellitus and Cardiovascular Diseases
Tyagi, A. C., Sen, U., & Mishra, P. K. (2011) · Current Diabetes Reviews · doi:10.2174/157339911797579179 · Cited by 35
miR-320a induces pancreatic β cells dysfunction in diabetes by inhibiting MafF
Du, H., Yin, Z., Zhao, Y., Li, H., Dai, B., Fan, J., He, M., Nie, X., Wang, C., Wang, D. W., et al. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.08.027 · Cited by 34
Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7
Bao, Y., Chen, B., Wu, Q., Hu, K., Xi, X., Zhu, W., Zhong, X., & Chen, J.-T. (2015) · Clinical and Experimental Medicine · doi:10.1007/s10238-015-0398-6 · Cited by 33
Gestational diabetes and maternal obesity are associated with sex-specific changes in miRNA and target gene expression in the fetus
Joshi, A. S., Azuma, R., Akumuo, R. C., Goetzl, L. M., & Pinney, S. E. (2019) · International Journal of Obesity · doi:10.1038/s41366-019-0485-y · Cited by 34
Targeting the microRNAs in exosome: A potential therapeutic strategy for alleviation of diabetes-related cardiovascular complication
Zhao, S., Wang, H., Xu, H., Tan, Y., Zhang, C., Zeng, Q., Liu, L., & Qu, S.-L. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105868 · Cited by 32
Modulation of microRNA 20b with resveratrol and longevinex is linked with their potent anti‐angiogenic action in the ischaemic myocardium and synergestic effects of resveratrol and γ‐tocotrienol
Mukhopadhyay, P., Das, S., Ahsan, M. K., Otani, H., & Das, D. K. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01480.x · Cited by 33
Exosomal non coding RNAs as a novel target for diabetes mellitus and its complications
Sufianov, A. A., Kostin, A. A., Begliarzade, S., Kudriashov, V., Ilyasova, T., Liang, Y., Mukhamedzyanov, A., & Beylerli, O. (2023) · Non-coding RNA Research · doi:10.1016/j.ncrna.2023.02.001 · Cited by 31
Serum microRNA Levels in Diabetes Mellitus
Mastropasqua, R., D’Aloisio, R., Costantini, E., Porreca, A., Ferro, G., Libertini, D., Reale, M., Nicola, M. D., Viggiano, P., Falconio, G., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11020284 · Cited by 29
Extracellular miRNAs in redox signaling: Health, disease and potential therapies
Ruiz, G. P., Camara, H., Fazolini, N. P. B., & Mori, M. A. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.004 · Cited by 30
Alteration of Aging‐Dependent Micro RNA s in Idiopathic Pulmonary Fibrosis
Nho, R. S. (2015) · Drug Development Research · doi:10.1002/ddr.21272 · Cited by 27
Clinical significance and expression of microRNA in diabetic patients with erectile dysfunction
JIANG, X., LUO, Y., Zhao, S., Chen, Q., Jiang, C., Dai, Y., CHEN, Y., & Cao, Z. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2443 · Cited by 28
Circulating miR-320a as a Predictive Biomarker for Left Ventricular Remodelling in STEMI Patients Undergoing Primary Percutaneous Coronary Intervention
Galeano-Otero, I., Toro, R. D., Rasco, A. G., Díaz, I., Mayoral-González, I., Guerrero-Márquez, F. J., Gutiérrez‐Carretero, E., Domínguez, S. C., de la Llera, L. S. D., Barón‐Esquivias, G., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041051 · Cited by 28
MicroRNA-126: Dual Role in Angiogenesis Dependent Diseases
Nammian, P., Razban, V., Tabei, S. M. B., & Asadi-Yousefabad, S.-L. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200504120737 · Cited by 28
Unique molecular signatures of microRNAs in ocular fluids and plasma in diabetic retinopathy
Smit‐McBride, Z., Nguyen, A. T., Yu, A. K., Modjtahedi, S. P., Hunter, A. A., Rashid, S., Moisseiev, E., & Morse, L. S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235541 · Cited by 28
Genetic module and miRNome trait analyses reflect the distinct biological features of endothelial progenitor cells from different anatomic locations
Cheng, C., Lo, H.-H., Huang, T.-S., Cheng, Y.-C., Chang, S.-T., Chang, S., & Wang, H. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-447 · Cited by 28
Inhibition of long noncoding RNA IGF2AS promotes angiogenesis in type 2 diabetes
Zhao, Z., Liu, B., Li, B., Song, C., Diao, H., Guo, Z., Li, Z., & Zhang, J. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.05.039 · Cited by 28
The relationship of plasma miR-503 and coronary collateral circulation in patients with coronary artery disease
Yu, F., Hou, J., Xuan, W., Zhang, C., & Meng, X. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.06.001 · Cited by 28
Comprehensive treatment of diabetic endothelial dysfunction based on pathophysiological mechanism
Liu, Z., Lu, J., Sha, W., & Lei, T. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1509884 · Cited by 34
MicroRNA Regulation of Angiogenesis and Arteriogenesis
Hans, F. P., Moser, M., Bode, C., & Grundmann, S. (2010) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2011.12.001 · Cited by 27
Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy
Mortuza, R., & Chakrabarti, S. (2013) · Heart Failure Reviews · doi:10.1007/s10741-013-9381-z · Cited by 27
MicroRNA-193-5p modulates angiogenesis through IGF2 in type 2 diabetic cardiomyopathy
Fan, Y., Shang, Y., Li, B., Dai, S., Wu, W., Cheng, L., & Wang, X. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.07.108 · Cited by 27
Self-citation
MiRNA Expression Profile of the Myocardial Tissue of Pigs with Coronary Microembolization
Su, Q., Li, L., Zhao, J., Sun, Y., & Yang, H. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000481699 · Cited by 27
Roles of non-coding RNA in diabetic cardiomyopathy
Yao, X., Huang, X., Chen, J., Lin, W., & Tian, J. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02252-9 · Cited by 28
A thorough analysis of diabetes research in China from 1995 to 2015: current scenario and future scope
Wu, Z., Jin, T., & Weng, J. (2018) · Science China Life Sciences · doi:10.1007/s11427-018-9377-y · Cited by 27
MicroRNA-29 regulates myocardial microvascular endothelial cells proliferation and migration in association with IGF1 in type 2 diabetes
Li, Z., Jiang, R., Yue, Q., & Peng, H. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.03.055 · Cited by 26
Role of Biomarkers in Predicting Diabetes Complications With Special Reference to Diabetic Foot Ulcers
Pichu, S., Patel, B. M., Apparsundaram, S., & Goyal, R. K. (2017) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0205 · Cited by 25
MicroRNAs induced in melanoma treated with combination targeted therapy of Temsirolimus and Bevacizumab
Wagenseller, A. G., Shada, A. L., D’Auria, K. M., Murphy, C., Sun, D., Molhoek, K. R., Papin, J. A., Dutta, A., & Slingluff, C. L. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-218 · Cited by 25
Regulatory Roles of miRNAs in Aging
Caravia, X. M., & López-Otı́n, C. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-22380-3_11 · Cited by 27
miRNAs and diabetes mellitus
Karolina, D. S., Armugam, A., Sepramaniam, S., & Jeyaseelan, K. (2012) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.12.21 · Cited by 25
MicroRNAs mediate metabolic stresses and angiogenesis
Patella, F., & Rainaldi, G. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0775-6 · Cited by 23
MicroRNA-363-3p/p21(Cip1/Waf1) axis is regulated by HIF-2α in mediating stemness of melanoma cells
Hao, T., Li, C., Ding, X., & Xing, X. J. (2019) · Neoplasma · doi:10.4149/neo_2018_180828n655 · Cited by 23
The role of blood flow and microRNAs in blood vessel development
Liu, D., Krueger, J., & le Noble, F. A. C. (2011) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103220dl · Cited by 23
MicroRNAs as regulators of cutaneous wound healing
Lai, W., & Siu, P. M. (2014) · Journal of Biosciences · doi:10.1007/s12038-014-9421-4 · Cited by 22
Expression profiling of circular RNAs and their potential role in early‑stage diabetic cardiomyopathy
Dong, S., Tu, C., Ye, X., Li, L., Zhang, M., Xue, A., Chen, S., Zhao, Z., Cong, B., Lin, J., et al. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11248 · Cited by 22
Self-citation
MiR‐492 impairs the angiogenic potential of endothelial cells
Patella, F., Leucci, E., Evangelista, M., Parker, B. J., Wen, J., Mercatanti, A., Rizzo, M., Chiavacci, E., Lund, A. H., & Rainaldi, G. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12085 · Cited by 22
Association of subcutaneous and visceral fat with circulating microRNAs in a middle-aged Japanese population
Munetsuna, E., Yamada, H., Ando, Y., Yamazaki, M., Tsuboi, Y., Kondo, M., Mizuno, G., Ishikawa, H., Sugimoto, K., Osakabe, K., et al. (2017) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563217735124 · Cited by 22
Angiotensin II prompts heart cell apoptosis via AT1 receptor-augmented phosphatase and tensin homolog and miR-320-3p functions to enhance suppression of the IGF1R-PI3K-AKT survival pathway
Lu, S., Hong, W.-Z., Tsai, B. C., Chang, Y.-C., Kuo, C., Mhone, T. G., Chen, R., Kuo, W., & Huang, C. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003285 · Cited by 21
Role of microRNAs in peripheral artery disease (Review)
Zhou, X., Yuan, P., & He, Y. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.978 · Cited by 21
Lung Diseases of the Elderly
Ascher, K. B., Elliot, S. J., Rubio, G. A., & Glassberg, M. K. (2017) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2017.07.001 · Cited by 20
Myocardial cell-to-cell communication via microRNAs
Ottaviani, L., Sansonetti, M., & Martins, P. A. D. C. (2018) · Non-coding RNA Research · doi:10.1016/j.ncrna.2018.05.004 · Cited by 21
Intercellular Crosstalk Via Extracellular Vesicles in Tumor Milieu as Emerging Therapies for Cancer Progression
Pătraș, L., & Banciu, M. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190701143845 · Cited by 21
4‐Phenyl butyric acid does not generally reduce glucose levels in rodent models of diabetes
Xu, T., Chen, R., Wang, P., Zhang, R., Ke, S., & Miao, C. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05328.x · Cited by 20
Biological activity of the e domain of the IGF-1Ec as addressed by synthetic peptides
Vassilakos, G., Philippou, Α., Tsakiroglou, P., & Koutsilieris, M. (2014) · HORMONES · doi:10.1007/bf03401333 · Cited by 19
Analysis of microRNA expression profile induced by AICAR in mouse hepatocytes
Liu, J., Liu, W., Ying, H., Zhao, W., & Zhang, H. (2012) · Gene · doi:10.1016/j.gene.2012.09.118 · Cited by 20
Gadd45α: A Novel Diabetes-Associated Gene Potentially Linking Diabetic Cardiomyopathy and Baroreflex Dysfunction
Wang, N., Yang, C., Xie, F., Sun, L., Su, X., Wang, Y., Wei, R., Zhang, R., Li, X., Yang, B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049077 · Cited by 19
Angiogenic Exosome-Derived microRNAs: Emerging Roles in Cardiovascular Disease
Zhang, T.-R., & Huang, W.-Q. (2020) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-020-10082-9 · Cited by 19
Revisiting the timing hypothesis: Biomarkers that define the therapeutic window of estrogen for stroke
Sohrabji, F., Selvamani, A., & Balden, R. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.06.002 · Cited by 19
Therapeutic knockdown of miR-320 improves deteriorated cardiac function in a pre-clinical model of non-ischemic diabetic heart disease
Ghosh, N., Fenton, S., van Hout, I., Jones, G. T., Coffey, S., Williams, M. J. A., Sugunesegran, R., Parry, D. J., Davis, P. J., Schwenke, D. O., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.07.007 · Cited by 18
A microRNA Link to Glioblastoma Heterogeneity
Singh, S. K., Vartanian, A., Burrell, K. E., & Zadeh, G. M. (2012) · Cancers · doi:10.3390/cancers4030846 · Cited by 19
Posttranscriptional Regulation of Insulin Family Ligands and Receptors
Panda, A. C., Grammatikakis, I., Yoon, J., & Abdelmohsen, K. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140919202 · Cited by 18
Differentially expressed miRNA profiles of serum derived extracellular vesicles from patients with acute ischemic stroke
Pir, G. J., Zahid, M., Akhtar, N., Ayadathil, R., Pananchikkal, S. V., Joseph, S., Morgan, D. M., Babu, B. M., Ui, R. T., Sivasankaran, S., et al. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149171 · Cited by 18
Role of microRNAs in regulation of insulin secretion and insulin signaling involved in type 2 diabetes mellitus
Mendonca, A., Thandapani, P., Nagarajan, P., Venkatesh, S., & Sujatha, S. (2022) · Journal of Biosciences · doi:10.1007/s12038-022-00295-2 · Cited by 17
Systematic profiling of mRNA and miRNA expression in the pancreatic islets of spontaneously diabetic Goto-Kakizaki rats
ZENG, L.-Q., WEI, S.-B., Sun, Y., Qin, W., Cheng, J., Mitchelson, K. R., & Xie, L. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2723 · Cited by 16
Regulation of microvascularization in heart failure - an endothelial cell, non-coding RNAs and exosome liaison
Juni, R. P., de Abreu, R. C., & Martins, P. A. D. C. (2017) · Non-coding RNA Research · doi:10.1016/j.ncrna.2017.01.001 · Cited by 16
Metabolic stress in the myocardium: Adaptations of gene expression
Crawford, P. A., & Schaffer, J. E. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.06.008 · Cited by 15
Bioinformatics analysis of microRNAs related to blood stasis syndrome in diabetes mellitus patients
Chen, R., Chen, M., Xiao, Y., Liang, Q., Cai, Y., Chen, L., & Fang, M. (2018) · Bioscience Reports · doi:10.1042/bsr20171208 · Cited by 16
Micro ribonucleic acid‐363 regulates the phosphatidylinositol 3‐kinase/threonine protein kinase axis by targeting NOTCH1 and forkhead box C2, leading to hepatic glucose and lipids metabolism disorder in type 2 diabetes mellitus
Peng, Y., Wang, P., He, X., Hong, M., & Liu, F. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13695 · Cited by 14
Regulating Polyamine Metabolism by miRNAs in Diabetic Cardiomyopathy
Kambis, T. N., Tofilau, H. M. N., Gawargi, F. I., Chandra, S., & Mishra, P. K. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01429-w · Cited by 14
The role of microRNAs in the pathophysiology, diagnosis, and treatment of diabetic cardiomyopathy
Rhman, M. A., & Owira, P. M. O. (2022) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgac066 · Cited by 14
The Effects of Transcranial Focused Ultrasound Stimulation of Nucleus Accumbens on Neuronal Gene Expression and Brain Tissue in High Alcohol-Preferring Rats
Deveci, E., Akbaş, F., Ergun, A. S., Kurtulmuş, A., Koçak, A. B., Boyraz, R. K., Tok, O. E., Aydın, M. Ş., Kılıç, Ö., Bozkurt, A., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03130-9 · Cited by 15
Inhibition of miR-200b Promotes Angiogenesis in Endothelial Cells by Activating The Notch Pathway.
Qiu, T., Huang, J., Wang, L., & Zhu, B. (2021) · PubMed Central · doi:10.22074/cellj.2021.7080 · Cited by 14
Role and mechanism of miRNA in cardiac microvascular endothelial cells in cardiovascular diseases
Yan, J., Zhong, X., Zhao, Y., & Wang, X. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1356152 · Cited by 15
Self-citation
Extracellular Vesicles in Diabetic Cardiomyopathy—State of the Art and Future Perspectives
Zygmunciak, P., Stróżna, K., Błażowska, O., & Mrozikiewicz‐Rakowska, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116117 · Cited by 15
Identifying microRNAs Possibly Implicated in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia: A Review
Tsamou, M., Kremers, F. A. C., Samaritakis, K. A., & Roggen, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179551 · Cited by 12
The Impact of Micro RNA-320a Serum Level on Severity of Symptoms and Cerebral Processing of Pain in Patients with Fibromyalgia
Hussein, M., Fathy, W., Abdelaleem, E. A., Nasser, M., Yehia, A., & Elanwar, R. (2022) · Pain Medicine · doi:10.1093/pm/pnac076 · Cited by 12
“Fishing” for endothelial microRNA functions and dysfunction
Santoro, M. M. (2011) · Vascular Pharmacology · doi:10.1016/j.vph.2011.08.224 · Cited by 12
The Role of miRNA in the Regulation of Angiogenesis in Ischemic Heart Disease
Sun, J., Ge, Y., Chao, T., Bai, R., & Wang, C. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.101637 · Cited by 11
Skewed Epigenetics: An Alternative Therapeutic Option for Diabetes Complications
Togliatto, G., Dentelli, P., & Brizzi, M. F. (2015) · Journal of Diabetes Research · doi:10.1155/2015/373708 · Cited by 11
Epigenetic Contribution to the Development and Progression of Vascular Diabetic Complications
Rodriguez, H., & El‐Osta, A. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7347 · Cited by 11
The role of non-protein-coding RNAs in ischemic acute kidney injury
Sarvestani, F. S., Afshari, A., & Azarpira, N. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1230742 · Cited by 10
Comprehensive patterns in microRNA regulation of transcription factors during tumor metastasis
Reshmi, G., Sona, C., & Pillai, M. R. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23148 · Cited by 10
Identification of miRNA Signature Associated With Erectile Dysfunction in Type 2 Diabetes Mellitus by Support Vector Machine-Recursive Feature Elimination
Xu, H., Zhao, B., Zhong, W. H., Teng, P., & Qiao, H. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.762136 · Cited by 10
Analyses of Copy Number Variation of GK Rat Reveal New Putative Type 2 Diabetes Susceptibility Loci
Ye, Z., Niu, S., Yu, Y., Yu, H., Liu, B. H., Li, R.-X., Xiao, H.-S., Zeng, R., Li, Y. X., Wu, J.-R., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014077 · Cited by 10
Diabetes, microRNAs and exosomes: Les liaisons dangereuses
Shantikumar, S., Angelini, G. D., & Emanueli, C. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.05.014 · Cited by 9

Authors: Wang, X., Qian, R., Zhang, W., Chen, S., Jin, H., & Hu, R.
Affiliations: Shanghai Medical College of Fudan University (CN)
ORCID: Chen, SF
Venue: Clinical and Experimental Pharmacology and Physiology
Publisher: Wiley
Published: 2009-01-27
Volume: 36
Issue: 2
Pages: 181-188
ISSN: 0305-1870 (ISSN-L)
1440-1681
DOI: 10.1111/j.1440-1681.2008.05057.x
OpenAlex: W2042150160
Cited by: 271
References: 38
Citations by year: 2026: 4 · 2025: 9 · 2024: 8 · 2023: 5 · 2022: 8 · 2021: 15 · 2020: 9 · 2019: 15 · 2018: 18 · 2017: 28 · 2016: 7 · 2015: 17 · 2014: 28 · 2013: 26 · 2012: 24
FWCI: 5.69
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Clinical and Experimental Pharmacology and Physiology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Keywords: type 2 diabetes, insulin-like growth factor I, IGF-1 receptor, impaired angiogenesis, Goto-Kakizaki rats, miRNA expression profiling, endothelial cell proliferation and migration, let-7e, miR-129, miR-370
MeSH terms: Animals, Cells, Cultured, Coronary Vessels, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2, Insulin-Like Growth Factor I, Myocardium, Transfection, Up-Regulation, Rats, Wistar, Neovascularization, Physiologic, Reverse Transcriptase Polymerase Chain Reaction, MicroRNAs, Endothelial Cells, Microarray Analysis, Rats, Microvessels

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

MicroRNA‐320 EXPRESSION IN MYOCARDIAL MICROVASCULAR ENDOTHELIAL CELLS AND ITS RELATIONSHIP WITH INSULIN‐LIKE GROWTH FACTOR‐1 IN TYPE 2 DIABETIC RATS

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks